Phibro Animal Health (PAHC) Downgraded by BidaskClub to “Sell”
Phibro Animal Health (NASDAQ:PAHC) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Tuesday.
PAHC has been the subject of a number of other reports. Zacks Investment Research cut shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, August 29th. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a research note on Wednesday, August 29th. Finally, Barclays boosted their price objective on shares of Phibro Animal Health from $31.00 to $33.00 and gave the stock an “underweight” rating in a research note on Thursday, July 5th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $43.20.
NASDAQ PAHC opened at $43.35 on Tuesday. The company has a quick ratio of 1.66, a current ratio of 2.90 and a debt-to-equity ratio of 1.62. The company has a market capitalization of $1.81 billion, a price-to-earnings ratio of 24.91, a price-to-earnings-growth ratio of 2.59 and a beta of 0.89. Phibro Animal Health has a 12-month low of $32.05 and a 12-month high of $54.62.
In other news, VP Daniel M. Bendheim sold 2,500 shares of the business’s stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total value of $110,750.00. Following the completion of the sale, the vice president now directly owns 2,500 shares in the company, valued at $110,750. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jack Bendheim sold 30,000 shares of the business’s stock in a transaction on Thursday, June 21st. The stock was sold at an average price of $47.56, for a total transaction of $1,426,800.00. The disclosure for this sale can be found here. Insiders sold 383,960 shares of company stock valued at $18,474,427 over the last 90 days. 51.88% of the stock is owned by corporate insiders.
Institutional investors have recently modified their holdings of the company. Alps Advisors Inc. acquired a new position in Phibro Animal Health during the 2nd quarter valued at $431,000. Prudential Financial Inc. raised its stake in Phibro Animal Health by 37.7% during the 1st quarter. Prudential Financial Inc. now owns 189,070 shares of the company’s stock valued at $7,506,000 after purchasing an additional 51,800 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Phibro Animal Health by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 482,718 shares of the company’s stock valued at $19,164,000 after purchasing an additional 4,674 shares during the last quarter. Royal Bank of Canada raised its stake in Phibro Animal Health by 2,104.6% during the 1st quarter. Royal Bank of Canada now owns 3,814 shares of the company’s stock valued at $151,000 after purchasing an additional 3,641 shares during the last quarter. Finally, Stevens First Principles Investment Advisors acquired a new position in Phibro Animal Health during the 2nd quarter valued at $569,000. Institutional investors and hedge funds own 50.45% of the company’s stock.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.